Bruker (BRKR) Corporation announced new updates from Bruker Spatial Biology to be showcased at the 2026 American Association for Cancer Research Annual Meeting. At AACR, Bruker Spatial Biology will highlight how its high-fidelity spatial platforms-designed to work together-deliver deeper insights into oncology biology and accelerate translational research. At AACR 2026, Bruker Spatial Biology will launch new cross-platform workflows linking GeoMx DSP to CellScape XR and CellScape XR to CosMx SMI, enabling researchers integrate insights across its spatial biology portfolio-revealing biological relationships that cannot be captured with a single modality alone. Bruker Spatial Biology will also debut new 208-plex datasets from CellScape XR, highlighting flexible subcellular proteomics for rapid, quantitative spatial phenotyping in oncology applications.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRKR:
- Bruker price target lowered to $45 from $50 at Barclays
- Bruker unveils NMR products, workflow solutions at ENC 2026
- Bruker Announces Planned Transition of BioSpin Group President
- Bruker invests in photothermal AFM-IR to advance semiconductor research
- Bruker Expands Board, Appoints Thierry Bernard as Director